Alphatec Holdings, Inc. (ATEC) vs Generate Biomedicines, Inc. (GENB)
A side-by-side comparison of Alphatec Holdings, Inc. and Generate Biomedicines, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATEC
Alphatec Holdings, Inc.
$10.77HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
GENB
Generate Biomedicines, Inc.
$13.69HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — ATEC vs GENB
growth of $100 · dividends reinvested · last 1yATEC -23.0% (-23.0%/yr)GENB +10.0% (+10.0%/yr)GENB compounded faster over this window
ATEC GENB
ATEC vs GENB: by the numbers
- •GENB is the larger company ($1.75B vs $1.66B market cap).
- •Both run net losses; ATEC's is the smaller (-13.50% vs -636.99% net margin).
Metrics side by side
Valuation
| Metric | ATEC | GENB |
|---|---|---|
| Forward P/E | 32.97 | N/A |
| P/S ratio | 2.03 | N/A |
| P/B ratio | N/A | 3.85 |
| EV / EBITDA | 57.60 | N/A |
| FCF yield | 0.25% | N/A |
Profitability
| Metric | ATEC | GENB |
|---|---|---|
| Gross margin | 66.15% | 100.00% |
| Operating margin | -5.55% | -737.04% |
| Net margin | -13.50% | -636.99% |
| ROIC | -7.32% | -94.79% |
Growth (annualized)
| Metric | ATEC | GENB |
|---|---|---|
| Revenue CAGR (5Y) | 33.61% | N/A |
| Total return CAGR (5Y) | -2.26% | N/A |
Go deeper
Dig into the metrics
Alphatec ROEGenerate Biomedicines ROEAlphatec operating marginGenerate Biomedicines operating marginAlphatec revenue growthGenerate Biomedicines revenue growthAlphatec free cash flowGenerate Biomedicines free cash flow
Alphatec & Generate Biomedicines appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.